APEX MEDICUS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 925,072 | 1,323,304 | 4,107,307 | 1,072,538 | 880,095 | 1,118,426 | 1,493,357 | 3,475,878 |
| Profit before tax | 11,761 | 69,224 | 203,537 | 9,383 | -132,221 | -48,883 | 198,048 | 456,026 |
| Net profit | 5,638 | 56,145 | 162,025 | 5,079 | -132,221 | -48,883 | 185,329 | 378,986 |
| Equity | 2,654,615 | 2,710,760 | 2,812,785 | 2,817,864 | 685,643 | 636,760 | 422,088 | 801,074 |
| Liabilities | 66,016 | 131,821 | 704,546 | 120,168 | 56,968 | 73,913 | 466,381 | 350,984 |
| Non-current assets | 90,884 | 66,893 | 51,919 | 40,331 | 36,787 | 41,231 | 42,543 | 98,083 |
| Current assets | 2,628,774 | 2,766,836 | 3,461,317 | 2,894,059 | 702,188 | 665,158 | 842,522 | 1,005,552 |
| Total assets | 2,719,658 | 2,833,729 | 3,513,236 | 2,934,390 | 738,975 | 706,389 | 885,065 | 1,103,635 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 181,894 | 259,649 | 723,668 |
| Social insurance contributions | - | - | - | - | - | 46,337 | 54,189 | 63,909 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -45.8% | +43.0% | +210.4% | -73.9% | -17.9% | +27.1% | +33.5% | +132.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.2% | 2.0% | 4.6% | 0.2% | -17.9% | -6.9% | 20.9% | 34.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.2% | 2.1% | 5.8% | 0.2% | -19.3% | -7.7% | 43.9% | 47.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.6% | 4.2% | 3.9% | 0.5% | -15.0% | -4.4% | 12.4% | 10.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.3% | 5.2% | 5.0% | 0.9% | -15.0% | -4.4% | 13.3% | 13.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.3 | 0.0 | 0.1 | 0.1 | 1.1 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 95,697 | 147,034 | 440,070 | 107,254 | 88,749 | 124,270 | 165,929 | 386,209 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
APEX MEDICUS - Social security debts
The company had no debts to Sodra
APEX MEDICUS - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
APEX MEDICUS, UAB (code 225471510) is a Private Limited Liability Company engaged in wholesale of pharmaceutical and medical goods. In the latest financial year 2025, revenue increased to €3.48M, up 132.8% year on year and 210.8% over two years. Net profit reached €379.0K, compared with €185.3K in 2024 and a loss of €48.9K in 2023, indicating a strong turnaround and continued expansion. The 2025 profit margin was 10.9%, slightly below 12.4% in 2024 but well above the negative margin recorded in 2023. The balance sheet also strengthened: total assets rose to €1.10M, equity to €801.1K, and liabilities stood at €351.0K. The equity ratio was 72.6%, while debt-to-equity was 0.44, suggesting a solid capital structure. Asset turnover reached 3.15x, with ROE at 47.3% and ROA at 34.3%. Revenue per employee was €386.2K and profit per employee €42.1K, reflecting strong operating productivity in 2025.